Recent Posts

FDA staff raises concerns over lack of safety data for sickle-cell treatment

BLOOMBERG The Food and Drug Administration’s (FDA) staff raised concerns about safety data on a potential gene-editing treatment for sickle cell disease, ahead of a closely watched meeting where scientific experts will weigh the first therapy using Crispr technology. FDA advisers are preparing to meet on October 31 to consider and discuss an application from Vertex Pharmaceuticals Inc and Crispr ...

Read More »

Advanced R&D in Dubai: HBS & BITS Pilani Partnership

AHMEDABAD / GULF TIME Exploring new horizons in medical and self-care technology requires collaborating with the best. The visionary founder of Kollagen wound care technology, Dr Manoj Jain and Human BioSciences President, Rohan Jain, traveled this past week to Dubai. The Jain Family met with leaders of the premier engineering institute of the UAE at the Birla Institute of Technology ...

Read More »
Send this to a friend